In this article, we will look at the 11 Best Stocks to Buy for the Next 3 Months According to Hedge Funds.
On September 6, Rebecca Patterson, Chief Investment Strategist at Bridgewater Associates, appeared in an interview on CNBC to discuss the current US economy. She noted that the economy, from a labour market perspective, is slowing and even stalling to some extent. She believes that this is due to the disconnect between GDP reports and labor market data expected in the coming months and quarters. Patterson emphasized focusing on the labor market and consumer spending, stating that as the labor market slows, consumers become more cautious with less income, eventually causing the equity market and GDP growth to falter.
While talking about the investment environment, she noted that the market should not assume that the Federal Reserve will bail out the market as it has done in the past cycles. Patterson highlighted that the Fed might cut rates but not as aggressively as markets expect unless the economy slows significantly or inflation falls. This, however, will not be good for the economy or the stock market. She noted on the bright side, even if the economy merely stalls, large-cap stocks and lower-volatility stocks could be better off in that situation.
She advised investors to look for companies that have structural support, such as AI beneficiaries, global defense, and utilities. She emphasized looking at companies with long-term structural trends rather than purely cyclical factors.
With that, let’s take a look at the 11 best stocks to buy for the next 3 months according to hedge funds.
Stocks
Our Methodology
To curate the list of 11 best stocks to buy for the next 3 months according to hedge funds, we used the Finviz stock screener, CNN, and Insider Monkey’s Q2 2025 hedge funds database. Using the screener, we aggregated a list of stocks that have performed well (up more than 25% over the past 6 months) and analysts still expect more than 25% upside. Next, from these stocks, we chose the ones on analysts’ and hedge funds’ radars, and ranked them in ascending order of the number of hedge fund holders.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
11 Best Stocks to Buy for the Next 3 Months According to Hedge Funds
11. Metsera, Inc. (NASDAQ:MTSR)
6-Month Performance: 40.83%
Analyst Upside Potential: 72.85%
Number of Hedge Fund Holders: 18
Metsera, Inc. (NASDAQ:MTSR) is one of the Best Stocks to Buy for the Next 3 Months According to Hedge Funds. On August 28, Bank of America Securities analyst Tim Anderson raised the firm’s price target on Metsera, Inc. (NASDAQ:MTSR) from $45 to $50, while maintaining a Buy rating on the stock.
The improved bullish sentiment for the stock comes after the company reported financial and business updates for its fiscal second quarter of 2025. The company reported notable progress in its obesity and metabolic disease drug pipeline for mid-2025. Its lead drug, MET-097i, which is a once-monthly GLP-1 receptor agonist, showed strong potential for weight loss and good tolerability in Phase 2b trials. Moreover, data from VESPER-1 and interim VESPER-3 studies are expected in September 2025.
Moreover, another drug, MET-233i, which is a once-monthly amylin analog, delivered impressive Phase 1 results, with an 8.4% weight loss over five weeks and a 19-day half-life. Management is expecting full 12-week monotherapy data by late 2025. Similarly, the company is also advancing oral peptide programs, with data from MET-097o and MET-224o expected in late 2025 as well.
Metsera, Inc. (NASDAQ:MTSR) is a clinical-stage biotechnology company developing innovative injectable and oral hormone analog peptides.
10. Venture Global, Inc. (NYSE:VG)
6-Month Performance: 39.11%
Analyst Upside Potential: 32.40%
Number of Hedge Fund Holders: 22
Venture Global, Inc. (NYSE:VG) is one of the Best Stocks to Buy for the Next 3 Months According to Hedge Funds. On August 27, Christopher Robertson from Deutsche Bank upgraded Venture Global, Inc. (NYSE:VG) from a Hold to a Buy rating with a $17 price target.
The analyst noted that Deutsche Bank visited the management at the Plaquemines LNG facility. During the visit, the firm was able to gain a clearer picture of the complexity and discipline of the company to simultaneously continue commissioning and construction work at its projects. The analyst noted that it takes a lot of effort and discipline to deliberately schedule the construction sequence, which has become one of the differentiation factors for Venture Global, Inc. (NYSE:VG). The company is known for using factory-built, mid-scale liquefaction trains.
Earlier on August 12, Venture Global, Inc. (NYSE:VG) delivered strong results for its fiscal second quarter of 2025. The revenue of $3.10 billion came in ahead of Wall Street consensus by $130.25 million. Management exported a record 89 cargos totaling 331 TBtu of liquefied natural gas, up from 53 cargos totaling 202 TBtu a year ago.
Venture Global, Inc. (NYSE:VG) provides liquefied natural gas (LNG) sourced from North American gas basins. It operates across the LNG supply chain, including production, transport, shipping, and regasification.
Hedge Fund Resource Center